Mirabegron (Betmiga▼): risk of severe hypertension and associated cerebrovascular and cardiac events

2015-10-14T12:55:40+01:00

Mirabegron is now contraindicated in patients with severe uncontrolled hypertension; advice about regular monitoring is being introduced because of cases of severe hypertension.